{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T01:42:26Z","timestamp":1762652546279,"version":"build-2065373602"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["CIS-144304","SMN-139151","CIS-144302","SMN-139150","SMN-139149","CIS-144301","SMN-139148","CIS-144303"],"award-info":[{"award-number":["CIS-144304","SMN-139151","CIS-144302","SMN-139150","SMN-139149","CIS-144301","SMN-139148","CIS-144303"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003579","name":"University of Toronto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003579","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015070","name":"Department of Psychiatry, University of Toronto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014405","name":"Centre for Addiction and Mental Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014405","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Health Research BC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010658","name":"St. Paul&apos;s Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010658","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.josat.2023.209158","type":"journal-article","created":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T10:46:53Z","timestamp":1693997213000},"page":"209158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Correlates of nonfatal overdose among treatment-seeking individuals with non-heroin opioid use disorder: Findings from a pragmatic, pan-Canadian, randomized control trial"],"prefix":"10.1016","volume":"155","author":[{"given":"Hannah","family":"Crepeault","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianping","family":"Ti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didier","family":"Jutras-Aswad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Le Foll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paxton","family":"Bach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupinder","family":"Brar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Eugenia","family":"Socias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.josat.2023.209158_bb0005","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1080\/10826080701204813","article-title":"Impact of substance dependence and dual diagnosis on the quality of life of heroin users seeking treatment","volume":"43","author":"Astals","year":"2009","journal-title":"Substance Use & Misuse"},{"year":"2016","series-title":"Administration of naloxone","author":"BC Centre for Disease Control","key":"10.1016\/j.josat.2023.209158_bb0010"},{"issue":"10182","key":"10.1016\/j.josat.2023.209158_bb0015","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(18)33078-2","article-title":"Management of opioid use disorder in the USA: Present status and future directions","volume":"393","author":"Blanco","year":"2019","journal-title":"The Lancet"},{"key":"10.1016\/j.josat.2023.209158_bb0020","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2147\/SAR.S108302","article-title":"Factors associated with opioid overdose: A 10-year retrospective study of patients in a large integrated health care system","volume":"7","author":"Boscarino","year":"2016","journal-title":"Substance Abuse and Rehabilitation"},{"issue":"1","key":"10.1016\/j.josat.2023.209158_bb0025","doi-asserted-by":"crossref","DOI":"10.1186\/s40621-017-0118-7","article-title":"Risk markers for fatal and non-fatal prescription drug overdose: A meta-analysis","volume":"4","author":"Brady","year":"2017","journal-title":"Injury Epidemiology"},{"issue":"4","key":"10.1016\/j.josat.2023.209158_bb0030","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1177\/1077558717722592","article-title":"Economic conditions and drug and opioid overdose deaths","volume":"76","author":"Brown","year":"2019","journal-title":"Medical Care Research and Review"},{"issue":"18","key":"10.1016\/j.josat.2023.209158_bb0035","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1503\/cmaj.170363","article-title":"Guideline for opioid therapy and chronic noncancer pain","volume":"189","author":"Busse","year":"2017","journal-title":"CMAJ"},{"key":"10.1016\/j.josat.2023.209158_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108384","article-title":"Overdose deaths involving psychostimulants with abuse potential, excluding cocaine: State-level differences and the role of opioids","volume":"218","author":"Cano","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209158_bb0045","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.drugalcdep.2016.02.024","article-title":"Non-fatal overdose as a risk factor for subsequent fatal overdose among people who inject drugs","volume":"162","author":"Caudarella","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.josat.2023.209158_bb0050","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","article-title":"The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis","volume":"34","author":"Ciccarone","year":"2021","journal-title":"Current Opinion in Psychiatry"},{"key":"10.1016\/j.josat.2023.209158_bb0055","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.drugpo.2019.07.030","article-title":"The prevalence of non-fatal overdose among people who inject drugs: A multi-stage systematic review and meta-analysis","volume":"73","author":"Colledge","year":"2019","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.josat.2023.209158_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103421","article-title":"Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS engage study","volume":"96","author":"Conway","year":"2021","journal-title":"The International Journal on Drug Policy"},{"key":"10.1016\/j.josat.2023.209158_bb0065","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.drugalcdep.2014.09.001","article-title":"Patterns and correlates of non-fatal heroin overdose at 11-year follow-up: Findings from the Australian treatment outcome study","volume":"144","author":"Darke","year":"2014","journal-title":"Drug and Alcohol Dependence"},{"issue":"693673","key":"10.1016\/j.josat.2023.209158_bb0070","article-title":"Understanding fatal and non-fatal drug overdose risk factors: Overdose risk questionnaire pilot study-validation","volume":"12","author":"Doggui","year":"2021","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.josat.2023.209158_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108127","article-title":"Socioeconomic marginalization and opioid-related overdose: A systematic review","volume":"214","author":"van Draanen","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209158_bb0080","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.drugpo.2017.06.005","article-title":"Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic","volume":"46","author":"Fairbairn","year":"2017","journal-title":"The International Journal on Drug Policy"},{"issue":"3","key":"10.1016\/j.josat.2023.209158_bb0085","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1503\/cmaj.1031416","article-title":"Determinants of overdose incidents among illicit opioid users in 5 Canadian cities","volume":"171","author":"Fischer","year":"2004","journal-title":"CMAJ"},{"issue":"1","key":"10.1016\/j.josat.2023.209158_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-020-8205-z","article-title":"Correlations between opioid mortality increases related to illicit\/synthetic opioids and reductions of medical opioid dispensing-exploratory analyses from Canada","volume":"20","author":"Fischer","year":"2020","journal-title":"BMC Public Health"},{"key":"10.1016\/j.josat.2023.209158_bb0095","first-page":"2005","article-title":"Patterns, changes, and trends in prescription opioid dispensing in Canada","volume":"21","author":"Fischer","year":"2018","journal-title":"Pain Physician"},{"issue":"4","key":"10.1016\/j.josat.2023.209158_bb0100","first-page":"5","article-title":"Prescription opioid use, harms and interventions in Canada: A review update of new developments and findings since 2010","volume":"18","author":"Fischer","year":"2015","journal-title":"Pain Physician"},{"key":"10.1016\/j.josat.2023.209158_bb0105","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.drugpo.2018.03.026","article-title":"Safe and unsafe spaces: Non-fatal overdose, arrest, and receptive syringe sharing among people who inject drugs in public and semi-public spaces in Baltimore City","volume":"57","author":"Hunter","year":"2018","journal-title":"International Journal of Drug Policy"},{"issue":"1","key":"10.1016\/j.josat.2023.209158_bb0110","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1080\/08897077.2021.1946892","article-title":"Increasing preference for fentanyl among a cohort of people who use opioids in Vancouver, Canada, 2017-2018","volume":"43","author":"Ickowicz","year":"2021","journal-title":"Substance Abuse"},{"issue":"1","key":"10.1016\/j.josat.2023.209158_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40545-020-00271-x","article-title":"Prescription opioid dispensing in Canada: An update on recent developments to 2018","volume":"13","author":"Jones","year":"2020","journal-title":"Journal of Pharmaceutical Policy and Practice"},{"issue":"10","key":"10.1016\/j.josat.2023.209158_bb0120","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1176\/appi.ajp.21090964","article-title":"Flexible buprenorphine\/naloxone model of care for reducing opioid use in individuals with prescription-type opioid use disorder: An open-label, pragmatic, noninferiority randomized controlled trial","volume":"179","author":"Jutras-Aswad","year":"2022","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1016\/j.josat.2023.209158_bb0125","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S2468-2667(21)00007-4","article-title":"Periods of altered risk for non-fatal drug overdose: A self-controlled case series","volume":"6","author":"Keen","year":"2021","journal-title":"The Lancet Public Health"},{"issue":"1","key":"10.1016\/j.josat.2023.209158_bb0130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.drugalcdep.2006.07.009","article-title":"Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users","volume":"87","author":"Kerr","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209158_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108989","article-title":"The association between prescription opioid dispensing and opioid-related morbidity and mortality in Ontario, Canada: An ecological study of public health units","volume":"227","author":"Ladha","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.josat.2023.209158_bb0140","first-page":"257","article-title":"Prescription opioid use and non-fatal overdose in a cohort of injection drug users","volume":"41","author":"Lake","year":"2015"},{"key":"10.1016\/j.josat.2023.209158_bb0145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jsat.2019.12.008","article-title":"Outreach to people who survive opioid overdose: Linkage and retention in treatment","volume":"111","author":"Langabeer","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.josat.2023.209158_bb0150","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.drugalcdep.2003.09.005","article-title":"Social network correlates of self-reported non-fatal overdose","volume":"73","author":"Latkin","year":"2004","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.josat.2023.209158_bb0155","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.annemergmed.2019.07.021","article-title":"One-year mortality after emergency department visit for nonfatal opioid poisoning: A population-based analysis","volume":"75","author":"Leece","year":"2020","journal-title":"Annals of Emergency Medicine"},{"issue":"11","key":"10.1016\/j.josat.2023.209158_bb0160","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2105\/AJPH.2015.302843","article-title":"Worldwide prevalence and trends in unintentional drug overdose: A systematic review of the literature","volume":"105","author":"Martins","year":"2015","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.josat.2023.209158_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.103039","article-title":"\u201cThat\u2019s why people don\u2019t call 911\u201d: Ending routine police attendance at drug overdoses","volume":"88","author":"van der Meulen","year":"2021","journal-title":"International Journal of Drug Policy"},{"issue":"1","key":"10.1016\/j.josat.2023.209158_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12954-021-00539-8","article-title":"Drug use, homelessness and health: Responding to the opioid overdose crisis with housing and harm reduction services","volume":"18","author":"Milaney","year":"2021","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.josat.2023.209158_bb0175","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugalcdep.2018.06.004","article-title":"Risks of fatal opioid overdose during the first year following nonfatal overdose","volume":"190","author":"Olfson","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209158_bb0180","unstructured":"Opioid- and stimulant-related harms in Canada - public health infobase | Public Health Agency of Canada. (n.d.). Retrieved October 5, 2021, from https:\/\/health-infobase.canada.ca\/substance-related-harms\/opioids-stimulants\/."},{"key":"10.1016\/j.josat.2023.209158_bb0185","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.drugpo.2016.05.010","article-title":"Illicit drug overdose deaths resulting from income assistance payments: Analysis of the \u201ccheck effect\u201d using daily mortality data","volume":"33","author":"Otterstatter","year":"2016","journal-title":"The International Journal on Drug Policy"},{"issue":"1","key":"10.1016\/j.josat.2023.209158_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12954-018-0240-z","article-title":"Fentanyl-contaminated drugs and non-fatal overdose among people who inject drugs in Baltimore, MD","volume":"15","author":"Park","year":"2018","journal-title":"Harm Reduction Journal"},{"issue":"6","key":"10.1016\/j.josat.2023.209158_bb0195","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/ADM.0000000000000245","article-title":"Understanding risk factors for opioid overdose in clinical populations to inform treatment and policy","volume":"10","author":"Park","year":"2016","journal-title":"Journal of Addiction Medicine"},{"issue":"7","key":"10.1016\/j.josat.2023.209158_bb0200","doi-asserted-by":"crossref","first-page":"529","DOI":"10.4236\/jss.2021.97038","article-title":"The challenge of polysubstance use overdose","volume":"9","author":"Pergolizzi","year":"2021","journal-title":"Open Journal of Social Sciences"},{"issue":"13","key":"10.1016\/j.josat.2023.209158_bb0205","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1177\/0042098014548138","article-title":"Pathways into homelessness: Understanding how both individual and structural factors contribute to and sustain homelessness in Canada","volume":"52","author":"Piat","year":"2014","journal-title":"Urban Studies"},{"issue":"3","key":"10.1016\/j.josat.2023.209158_bb0210","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/add.15182","article-title":"Drug-related harm coinciding with income assistance payments: Results from a community-based cohort of people who use drugs","volume":"116","author":"Richardson","year":"2021","journal-title":"Addiction"},{"issue":"11","key":"10.1016\/j.josat.2023.209158_bb0215","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.2105\/AJPH.91.11.1842","article-title":"Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998-1999","volume":"91","author":"Seal","year":"2001","journal-title":"American Journal of Public Health"},{"issue":"1\u20132","key":"10.1016\/j.josat.2023.209158_bb0220","first-page":"104","article-title":"Factors associated with history of non-fatal overdose among young nonmedical users of prescription drugs","volume":"128","author":"Silva","year":"2013"},{"key":"10.1016\/j.josat.2023.209158_bb0225","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cct.2018.04.001","article-title":"The OPTIMA study, buprenorphine\/naloxone and methadone models of care for the treatment of prescription opioid use disorder: Study design and rationale","volume":"69","author":"Socias","year":"2018","journal-title":"Contemporary Clinical Trials"},{"key":"10.1016\/j.josat.2023.209158_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102696","article-title":"Trajectories of retention in opioid agonist therapy in a Canadian setting","volume":"77","author":"Soc\u00edas","year":"2020","journal-title":"International Journal of Drug Policy"},{"issue":"10","key":"10.1016\/j.josat.2023.209158_bb0235","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1111\/add.15954","article-title":"Impact of fentanyl use on initiation and discontinuation of methadone and buprenorphine\/naloxone among people with prescription-type opioid use disorder: Secondary analysis of a Canadian treatment trial","volume":"117","author":"Socias","year":"2022","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.josat.2023.209158_bb0240","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1465-3362.2009.00057.x","article-title":"Overdose deaths following previous non-fatal heroin overdose: Record linkage of ambulance attendance and death registry data","volume":"28","author":"Stoov\u00e9","year":"2009","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.josat.2023.209158_bb0245","series-title":"The Beck depression inventory, Second Edition (BDI-II): A cross-sample structural analysis. Measurement and evaluation in counseling and development","volume":"074817561666401","author":"Strunk","year":"2016"},{"key":"10.1016\/j.josat.2023.209158_bb0250","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugalcdep.2016.11.033","article-title":"A review: Fentanyl and non-pharmaceutical fentanyls","volume":"171","author":"Suzuki","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.josat.2023.209158_bb0255","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/10826084.2018.1491051","article-title":"Factors associated with nonfatal overdose during a public health emergency","volume":"54","author":"Wallace","year":"2019","journal-title":"Substance Use & Misuse"},{"issue":"1","key":"10.1016\/j.josat.2023.209158_bb0260","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.annemergmed.2019.04.020","article-title":"One-year mortality of patients after emergency department treatment for nonfatal opioid overdose","volume":"75","author":"Weiner","year":"2020","journal-title":"Annals of Emergency Medicine"},{"issue":"2","key":"10.1016\/j.josat.2023.209158_bb0265","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1080\/10903127.2021.1884324","article-title":"Non-transport after prehospital naloxone administration is associated with higher risk of subsequent non-fatal overdose","volume":"26","author":"Zozula","year":"2022","journal-title":"Prehospital Emergency Care"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923002096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923002096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T01:40:11Z","timestamp":1762652411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875923002096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":53,"alternative-id":["S2949875923002096"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2023.209158","relation":{},"ISSN":["2949-8759"],"issn-type":[{"type":"print","value":"2949-8759"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlates of nonfatal overdose among treatment-seeking individuals with non-heroin opioid use disorder: Findings from a pragmatic, pan-Canadian, randomized control trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2023.209158","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"209158"}}